Unknown

Dataset Information

0

Interleukin-1 in lipopolysaccharide induced chorioamnionitis in the fetal sheep.


ABSTRACT: We tested the hypothesis that interleukin 1 (IL-1) mediates intra-amniotic lipopolysaccharide (LPS)-induced chorioamnionitis in preterm fetal sheep. Time-mated Merino ewes with singleton fetuses received IL-1?, LPS, or saline (control) by intra-amniotic injection 1 to 2 days before operative delivery at 124 ± 1 days gestational age (N = 5-9/group; term = 150 days). Recombinant human IL-1 receptor antagonist (rhIL-1ra) was given into the amniotic fluid 3 hours before intra-amniotic LPS or saline to block IL-1 signaling. Inflammation in the chorioamnion was determined by histology, cytokine messenger RNA (mRNA), protein expression, and by quantitation of activated inflammatory cells. Intra-amniotic IL-1 and LPS both induced chorioamnionitis. However, IL-1 blockade with IL-1ra did not decrease intra-amniotic LPS-induced increases in pro-inflammatory cytokine mRNAs, numbers of inflammatory cells, myeloperoxidase, or monocyte chemotactic protein-1-expressing cells in the chorioamnion. We conclude that IL-1 and LPS both can cause chorioamnionitis, but IL-1 is not an important mediator of LPS-induced chorioamnionitis in fetal sheep.

SUBMITTER: Berry CA 

PROVIDER: S-EPMC3343143 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interleukin-1 in lipopolysaccharide induced chorioamnionitis in the fetal sheep.

Berry Clare A CA   Nitsos Ilias I   Hillman Noah H NH   Pillow J Jane JJ   Polglase Graeme R GR   Kramer Boris W BW   Kemp Matthew W MW   Newnham John P JP   Jobe Alan H AH   Kallapur Suhas G SG  

Reproductive sciences (Thousand Oaks, Calif.) 20110414 11


We tested the hypothesis that interleukin 1 (IL-1) mediates intra-amniotic lipopolysaccharide (LPS)-induced chorioamnionitis in preterm fetal sheep. Time-mated Merino ewes with singleton fetuses received IL-1α, LPS, or saline (control) by intra-amniotic injection 1 to 2 days before operative delivery at 124 ± 1 days gestational age (N = 5-9/group; term = 150 days). Recombinant human IL-1 receptor antagonist (rhIL-1ra) was given into the amniotic fluid 3 hours before intra-amniotic LPS or saline  ...[more]

Similar Datasets

| S-EPMC3817667 | biostudies-literature
| S-EPMC3365024 | biostudies-literature
| S-EPMC4868637 | biostudies-literature
| S-EPMC7257152 | biostudies-literature
| S-EPMC8794675 | biostudies-literature
| S-EPMC8408978 | biostudies-literature
| S-EPMC5362269 | biostudies-literature
| S-EPMC2684020 | biostudies-literature
| S-EPMC3517680 | biostudies-literature
| S-EPMC6669419 | biostudies-literature